1. Home
  2. REAX vs EMBC Comparison

REAX vs EMBC Comparison

Compare REAX & EMBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo The Real Brokerage Inc.

REAX

The Real Brokerage Inc.

HOLD

Current Price

$4.28

Market Cap

790.0M

Sector

N/A

ML Signal

HOLD

Logo Embecta Corp.

EMBC

Embecta Corp.

HOLD

Current Price

$11.81

Market Cap

719.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
REAX
EMBC
Founded
2018
1924
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
790.0M
719.7M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
REAX
EMBC
Price
$4.28
$11.81
Analyst Decision
Strong Buy
Buy
Analyst Count
3
2
Target Price
$6.33
$18.50
AVG Volume (30 Days)
1.2M
733.6K
Earning Date
10-30-2025
11-25-2025
Dividend Yield
N/A
4.99%
EPS Growth
N/A
20.90
EPS
N/A
1.62
Revenue
$1,813,907,000.00
$1,080,400,000.00
Revenue This Year
$56.57
$2.18
Revenue Next Year
$21.77
$0.09
P/E Ratio
N/A
$7.43
Revenue Growth
65.60
N/A
52 Week Low
$3.42
$9.20
52 Week High
$5.65
$21.23

Technical Indicators

Market Signals
Indicator
REAX
EMBC
Relative Strength Index (RSI) 64.79 38.69
Support Level $3.92 $11.02
Resistance Level $3.99 $12.56
Average True Range (ATR) 0.15 0.67
MACD 0.05 -0.10
Stochastic Oscillator 71.76 20.72

Price Performance

Historical Comparison
REAX
EMBC

About REAX The Real Brokerage Inc.

The Real Brokerage Inc is a technology-powered real estate brokerage firm located in the United States and Canada. It has developed a proprietary transaction management and brokerage operations software called reZEN, which powers nearly all of its brokerage operations, enabling efficiency, automation, and flexibility by incorporating end-to-end transaction management, automated compliance and brokerage oversight, integrated payments and financial services, Leo CoPilot, and open API for customization. In addition, the company also offers mortgage brokering and title services. The company's operating segments are North American Brokerage, which derives key revenue, One Real Title, One Real Mortgage, and Real Wallet. Geographically, it derives key revenue from the United States.

About EMBC Embecta Corp.

Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.

Share on Social Networks: